Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-22

FDA Approved: DRAXIMAGE DTPA — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

View source ↗

Summary

FDA approved a supplemental application for DRAXIMAGE DTPA, a kit used to prepare technetium-99m DTPA for nuclear medicine imaging, to support continued clinica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DRAXIMAGE DTPA (Kit for the preparation of technetium-99m pentetate)

Snippet

SUPPL AP for DRAXIMAGE DTPA (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M PENTETATE)